跳至主要内容
临床试验/NCT01361685
NCT01361685已完成不适用

Attain Ability® Family Left Ventricular Lead Chronic Performance Study

Medtronic50 个研究点 分布在 3 个国家目标入组 366 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Medtronic
入组人数
366
试验地点
50
主要终点
Model 4396 LV Lead-related complication rate

研究概览

简要总结

Lead survivability will be summarized.

详细描述

The purpose of this study is to evaluate long-term performance of the 4396 LV Lead. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4396 LV Lead. This study is conducted within Medtronic's post-market surveillance platform.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Model 4396 LV Lead-related complication rate

时间窗: 5 years

次要结局

  • Bipolar pacing impedance(1 year)
  • Bipolar pacing capture threshold(1 year)
  • Number of fractures with and without loss of function(5 years)
  • Types of lead-related adverse device effects(5 years)
  • Bipolar electrical performance at 1 year(1 year)
  • Percent of subjects with changes in electrode programming(5 years)

研究者

发起方
Medtronic
申办方类型
Industry
责任方
Sponsor

研究点 (50)

Loading locations...

相似试验